Patent: 8,986,282
✉ Email this page to a colleague
Summary for Patent: 8,986,282
Title: | Methods, compositions and apparatus for delivering heterologous molecules to cells |
Abstract: | A method for transferring a macromolecular complex to muscle cells by exsanguinating a region of the subject\'s microvasculature and delivering the complex to this region under high hydrostatic pressure. A balloon catheter having a balloon that extends substantially the full length of the cannula that is inserted into the subject is provided for use in the systemic delivery of macromolecular complex. |
Inventor(s): | Stedman; Hansell H. (Norristown, PA), Bridges; Charles R. (Charlotte, NC) |
Assignee: | The Trustees of the University of Pennsylvania (Philadelphia, PA) |
Application Number: | 13/668,701 |
Patent Claims: | see list of patent claims |
Details for Patent 8,986,282
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 01/15/1974 | ⤷ Try a Trial | 2039-02-26 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 12/27/1984 | ⤷ Try a Trial | 2039-02-26 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/15/1985 | ⤷ Try a Trial | 2039-02-26 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/16/1990 | ⤷ Try a Trial | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |